UCB
UCB | BR
Overview
Corporate Details
- ISIN(s):
- BE0002730118 (+5 more)
- LEI:
- 2138008J191VLSGY5A09
- Country:
- Belgium
- Address:
- ALLÉE DE LA RECHERCHE 60, 1070 ANDERLECHT
- Website:
- https://www.ucb.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
A global biopharma company, inspired by the needs of people living with severe diseases. At UCB, we are consistently delivering on our commitment to improve the lives of people living with severe neurological and immunological conditions. And thanks to our focused, innovative and trusted solutions, our business is strong. Our people have lived our purpose each day since 1928, making critical investments in biopharmaceutical research and leading innovations that strive to achieve a meaningful impact on the lives of those we serve. UCB’s ambition is to transform the lives of people living with severe diseases, allowing them to live the best life that they can – as free as possible from the challenges and uncertainty of disease. That commitment comes to life in our research and development activities across neurology, immunology and other areas where our expertise, innovation and ambition align with unmet needs.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-16 20:00 |
Declaration of Voting Results & Voting Rights Announcements
EN PR FMR 16.06.25.pdf
|
English | 348.6 KB | |
| 2025-06-16 20:00 |
Declaration of Voting Results & Voting Rights Announcements
FR PR FMR 16.06.25.pdf
|
French | 304.0 KB | |
| 2025-06-16 20:00 |
Declaration of Voting Results & Voting Rights Announcements
NL PR FMR 16.06.25.pdf
|
Dutch | 304.2 KB | |
| 2025-05-07 10:30 |
General Meeting Notice
EN Minutes AGM 24.04.25 WEBSITE.pdf
|
English | 308.4 KB | |
| 2025-05-07 10:30 |
General Meeting Notice
FR Minutes AGM 24.04.25 WEBSITE.pdf
|
French | 323.5 KB | |
| 2025-05-07 10:30 |
General Meeting Notice
NL Minutes AGM 24.04.25 WEBSITE.pdf
|
Dutch | 328.4 KB | |
| 2025-03-21 07:00 |
Remuneration Report
8.1. Remuneration_Policy_2025_EN.pdf
|
English | 679.2 KB | |
| 2025-03-21 07:00 |
Annual Report
3.2 UCB SA_Management Report Statutory Accounts 2024 FR Final.pdf
|
French | 1.1 MB | |
| 2025-03-21 07:00 |
Remuneration Report
9.3. Explanatory Note on Remuneration_NL.pdf
|
Dutch | 327.7 KB | |
| 2025-03-21 07:00 |
Remuneration Report
9.1 Explanatory Note on Remuneration_EN.pdf
|
English | 244.2 KB | |
| 2025-03-21 07:00 |
Annual Audited Financial Statements
4.2 UCB_SA_Statutory Auditor Report 2024 FR.pdf
|
French | 199.5 KB | |
| 2025-03-21 07:00 |
Remuneration Report
8.3. Remuneration_Policy_2025_NL.pdf
|
Dutch | 622.5 KB | |
| 2025-03-21 07:00 |
Remuneration Report
7.1. ENG_Remuneration Report 2024.pdf
|
English | 197.0 KB | |
| 2025-03-21 07:00 |
Proxy Solicitation & Information Statements
2.2 Proxy General Meeting 24 April 2025 - FR - Final.pdf
|
French | 1.1 MB | |
| 2025-03-21 07:00 |
Remuneration Report
7.3. NL_ Remuneration Report 2024.pdf
|
Dutch | 206.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-08 | Johnson Waynick Denelle | Executive member | Buy | 56 | 6,571.60 EUR |
| 2024-06-30 | Patel Dhavalkumar | Executive member | Buy | 6,650 | 918,232.00 EUR |
| 2024-06-30 | Patel Dhavalkumar | Executive member | Buy | 4,648 | 641,795.84 EUR |
| 2024-06-30 | Patel Dhavalkumar | Executive member | Buy | 3,213 | 443,651.04 EUR |
| 2024-06-24 | Loew-Friedrich Iris | Executive member | Sell | 7,460 | 1,044,400.00 EUR |
| 2024-06-24 | Loew-Friedrich Iris | Executive member | Buy | 7,460 | 493,702.80 EUR |
| 2024-06-20 | Loew-Friedrich Iris | Executive member | Sell | 5,000 | 682,500.00 EUR |
| 2024-06-18 | Caeymaex Emmanuel | Executive member | Sell | 1,904 | 263,275.60 EUR |
| 2024-06-13 | Loew-Friedrich Iris | Executive member | Sell | 7,000 | 952,105.00 EUR |
| 2024-06-13 | Loew-Friedrich Iris | Executive member | Sell | 5,000 | 675,000.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP |